Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia

European Heart Journal

Volumn 25, Issue 15, 2004, Pages 1310-1317

  Ballo, Piercarlo ^a   Bernabò, Daniele ^a   Faraguti, Sergio Antonio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adenosine; Heart rate; Supraventricular tachycardia; Vagal manoeuvres; Verapamil

Indexed keywords

ADENOSINE; VERAPAMIL;

ADULT; ARTICLE; CAROTID SINUS MASSAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADENOSINE; ADOLESCENT; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; CAROTID SINUS; FEMALE; HEART RATE; HUMANS; MALE; MASSAGE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, PAROXYSMAL; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME; VERAPAMIL;

EID: 3242875987     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.05.011     Document Type: Article

References (103)

1. Orejarena L.A., Vidaillet H.J.R., DeStefano F., et al. Paroxysmal supraventricular tachycardia in the general population. J. Am. Coll. Cardiol. 31:1998;150-157
2. Luber S., Brady W.J., Joyce T., et al. Paroxysmal supraventricular tachycardia: outcome after ED care. Am. J. Emerg. Med. 19:2001;40-42
3. Kadish A., Passman R. Mechanisms and management of paroxysmal supraventricular tachycardia. Cardiol. Rev. 7:1999;254-264
4. Paparella N., Alboni P. Classification and prevalence of supraventricular tachyarrhythmia. Cardiologia. 36:1991;7-10
5. Brembilla-Perrot B., Houriez P., Beurrier D., et al. Influence of age on the electrophysiological mechanism of paroxysmal supraventricular tachycardias. Int. J. Cardiol. 78:2001;293-298
6. Accardi A.J., Miller R., Holmes J.F. Enhanced diagnosis of narrow complex tachycardias with increased electrocardiograph speed. J. Emerg. Med. 22:2002;123-126
7. Kalbfleisch S.J., el-Atassi R., Calkins H., et al. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J. Am. Coll. Cardiol. 21:1999;85-89
8. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: 7D: the tachycardia algorithms. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000;102:I158-65
9. Junga G., Candinas R. Schweiz Modern therapy of paroxysmal supraventricular tachycardia. Rundsch. Med. Prax. 88:1999;273-277
10. Paul T., Bertram H., Bokenkamp R., et al. Supraventricular tachycardia in infants, children and adolescents: diagnosis, and pharmacological and interventional therapy. Paediatr. Drugs. 2:2000;171-181
11. Brady W.J. Jr., DeBehnke D.J., Wickman L.L., et al. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad. Emerg. Med. 3:1996;574-585
12. Gil Madre J., Lazaro Rodriguez S., Sentenac Merchan G., et al. Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia: a comparison with verapamil. Rev. Esp. Cardiol. 48:1995;55-58
13. Davis R., Spitalnic S.J., Jagminas L. Cost-effective adenosine dosing for the treatment of PSVT. Am. J. Emerg. Med. 17:1999;633-634
14. Lee K.L., Chun H.M., Liem L.B., et al. Effect of adenosine and verapamil in catecholamine-induced accelerated atrioventricular junctional rhythm: insights into the underlying mechanism. Pacing Clin. Electrophysiol. 22:1999;866-870
15. Kirton O.C., Windsor J., Wedderburn R., et al. Management of paroxysmal atrioventricular nodal reentrant tachycardia in the critically ill surgical patient. Crit. Care Med. 25:1997;761-766
16. Lim S.H., Anantharaman V., Teo W.S., et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann. Emerg. Med. 31:1998;30-35
17. Lai W.T., Lee C.S., Wu S.N. Rate-dependent properties of adenosine-induced negative dromotropism in humans. Circulation. 90:1994;1832-1839
18. Schwarzl I., Stark U., Kasper K., et al. Quantification of rate-dependent effects of verapamil, diltiazem, and digoxin on atrioventricular conduction. J. Pharmacol. Toxicol. Methods. 36:1996;205-210
19. Stark G., Sterz F., Stark U., et al. Frequency-dependent effects of adenosine and verapamil on atrioventricular conduction of isolated guinea pig hearts. J. Cardiovasc. Pharmacol. 21:1993;955-959
20. Nayebpour M., Billette J., Amellal F., et al. Effects of adenosine on rate-dependent atrioventricular nodal function. Potential roles in tachycardia termination and physiological regulation. Circulation. 88:1993;2632-2645
21. Chiale P.A., Franco D.A., Selva H.O., et al. Lidocaine-sensitive atrial tachycardia: lidocaine-sensitive, rate-related, repetitive atrial tachycardia: a new arrhythmogenic syndrome. J. Am. Coll. Cardiol. 36(1):2000;1637-1645
22. Kwaku K.F., Josephson M.E. Typical AVNRT - an update on mechanisms and therapy. Card. Electrophysiol. Rev. 6:2002;414-421
23. Nawata H., Yamamoto N., Hirao K., et al. Heterogeneity of anterograde fast-pathway and retrograde slow-pathway conduction patterns in patients with the fast-slow form of atrioventricular nodal reentrant tachycardia: electrophysiological and electrocardiographic considerations. J. Am. Coll. Cardiol. 32:1998;1731-1740
24. Delise P., Bonso A., Coro L., et al. Pacemapping of the triangle of Koch: a simple method to reduce the risk of atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia. Pacing Clin. Electrophysiol. 24:2001;1725-1731
25. Heinroth K.M., Kattenbeck K., Stabenow I., et al. Multiple AV nodal pathways in patients with AV nodal reentrant tachycardia-more common than expected. Europace. 4:2002;375-382
26. Wu J., Zipes D.P. Mechanisms underlying atrioventricular nodal conduction and the reentrant circuit of atrioventricular nodal reentrant tachycardia using optical mapping. J. Cardiovasc. Electrophysiol. 13:2002;831-834
27. Luria D.M., Chugh S.S., Munger T.M., et al. Electrophysiologic characteristics of diverse accessory pathway locations of antidromic reciprocating tachycardia. Am. J. Cardiol. 86:2000;1333-1338
28. Davidson N.C., Morton J.B., Sanders P., et al. Latent Mahaim fiber as a cause of antidromic reciprocating tachycardia: recognition and successful radiofrequency ablation. J. Cardiovasc. Electrophysiol. 13:2002;74-78
29. Shah D.C., Haissaguerre M., Jais P., et al. High-resolution mapping of tachycardia originating from the superior vena cava: evidence of electrical heterogeneity, slow conduction, and possible circus movement reentry. J. Cardiovasc. Electrophysiol. 13:2002;388-392
30. Matsuoka K., Kasai A., Fujii E., et al. Electrophysiological features of atrial tachycardia arising from the atrioventricular annulus. Pacing Clin. Electrophysiol. 25:2002;440-445
31. Katritsis D., Giazitzoglou E., Korovesis S., et al. Epicardial foci of atrial arrhythmias apparently originating in the left pulmonary veins. J. Cardiovasc. Electrophysiol. 13:2002;319-323
32. Hegbom F., Hoff P.I., Rossvoll O., et al. A typical P-wave morphology in incessant atrial tachycardia originating from the right upper pulmonary vein. Scand. Cardiovasc. J. 34:2000;277-280
33. Ouyang F., Ernst S., Vogtmann T., et al. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence. Circulation. 105(23):2002;1934-1942
34. Markowitz S.M., Brodman R.F., Stein K.M., et al. Lesional tachycardias related to mitral valve surgery. J. Am. Coll. Cardiol. 39(19):2002;1973-1983
35. Marrouche N.F., Sippens Groenewegen A., Yang Y., et al. Clinical and electrophysiological characteristics of left septal atrial tachycardia. J. Am. Coll. Cardiol. 40(18):2002;1133-1139
36. Dong J., Schreieck J., Ndrepepa G., et al. Ectopic tachycardia originating from the superior vena cava. J. Cardiovasc. Electrophysiol. 13:2002;620-624
37. Ma G., Brady W.J., Pollack M., et al. Electrocardiographic manifestations: digitalis toxicity. J. Emerg. Med. 20:2001;145-152
38. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM et al. European Society of Cardiology Committee, NASPE-Heart Rhythm Society. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003;42:1493-531
39. Ferguson J.D., DiMarco J.P. Contemporary management of paroxysmal supraventricular tachycardia. Circulation. 107:2003;1096-1099
40. Hebbar A.K., Hueston W.J. Management of common arrhythmias: Part I. Supraventricular arrhythmias. Am. Fam. Physician. 65(15):2002;2479-2486
41. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: section 5: pharmacology I: agents for arrhythmias. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000;102:I-112-28
42. Lim S.H., Anantharaman V., Teo W.S. Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia. Resuscitation. 52:2002;167-174
43. Gupta A., Naik A., Vora A., et al. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. J. Assoc. Physicians India. 47:1999;969-972
44. Dougherty A.H., Jackman W.M., Naccarelli G.V., et al. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group. Am. J. Cardiol. 70:1992;587-592
45. Balser J.R., Martinez E.A., Winters B.D., et al. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology. 89:1998;1052-1059
46. Barbier G.H., Shettigar U.R., Appunn D.O. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. Int. J. Clin. Pharmacol. Ther. 33:1995;212-218
47. Reimold S.C., Maisel W.H., Antman E.M. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis. Am. J. Cardiol. 82:1998;66N-71N
48. Gambhir D.S., Bhargava M., Arora R., et al. Electrophysiological effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Indian Heart J. 47:1995;237-243
49. Page R.L., Connolly S.J., Wilkinson W.E., et al. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response. Am. Heart J. 143:2002;643-649
50. Tendera M., Wnuk-Wojnar A.M., Kulakowski P., et al. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am. Heart J. 142:2001;93-98
51. Pritchett E.L., Wilkinson W.E. Effect of dofetilide on survival in patients with supraventricular arrhythmias. Am. Heart J. 138:1999;994-997
52. Gambhir D.S., Bhargava M., Nair M., et al. Comparison of electrophysiological effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Indian Heart J. 48:1996;133-137
53. Price J.F., Kertesz N.J., Snyder C.S., et al. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age. J. Am. Coll. Cardiol. 39:2002;517-520
54. Alboni P., Tomasi C., Menozzi C., et al. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J. Am. Coll. Cardiol. 37:2001;548-553
55. Lerman B.B., Ellenbogen K.A., Kadish A., et al. Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans. J. Cardiovasc. Pharmacol. Ther. 6:2001;237-245
56. Ellenbogen KA. Randomized, double-blind, placebo-controlled study of intravenous CVT-510 in patients with PSVT undergoing an electrophysiologic study. Program and abstracts from American Heart Association Scientific Sessions 2002, November 17-20, 2002; Chicago, IL
57. Volkmann H., Dannberg G., Heinke M., et al. Termination of tachycardias by transesophageal electrical pacing. Pacing Clin. Electrophysiol. 15:1992;1962-1966
58. Lowenstein S.R., Halperin B.D., Reiter M.J. Paroxysmal supraventricular tachycardias. J. Emerg. Med. 14:1996;39-51
59. Pfammatter J.P., Bauersfeld U. Safety issues in the treatment of paediatric supraventricular tachycardias. Drug Saf. 18:1998;345-356
60. Mathew J., Hunsberger S., Fleg J., et al. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest. 118:2000;914-922
61. Jaeggi E., Fouron J.C., Fournier A., et al. Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia. Heart. 79:1998;582-587
62. Knight B.P., Ebinger M., Oral H., et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J. Am. Coll. Cardiol. 36:2000;574-582
63. Matsui Y., Iwasaka T., Karakawa M., et al. Left ventricular systolic time intervals during paroxysmal supraventricular tachycardia: the difference between A-V nodal re-entry and A-V re-entry. J. Cardiol. 22:1992;679-685
64. Knight B.P., Zivin A., Souza J., et al. A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J. Am. Coll. Cardiol. 33:1999;775-781
65. Akhtar M., Jazayeri M.R., Sra J., et al. Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation. 88:1993;282-295
66. Nakagawa H., Jackman W.M. Catheter ablation of macroreentrant atrial tachycardia in patients following atriotomy. Eur. Heart J. 23:2002;1566-1568
67. Kopf G.S., Mello D.M., Kenney K.M., et al. Intraoperative radiofrequency ablation of the atrium: effectiveness for treatment of supraventricular tachycardia in congenital heart surgery. Ann. Thorac. Surg. 74:2002;797-804
68. Wetzel U., Hindricks G., Schirdewahn P., et al. A stepwise mapping approach for localization and ablation of ectopic right, left, and septal atrial foci using electroanatomic mapping. Eur. Heart J. 23:2002;1387-1393
69. Cauchemez B., Lavergne T., Extramiana F., et al. Endocavitary ablation for arrhythmias. New modalities of radiofrequency applications. New energy types. Arch. Mal. Coeur. Vaiss. 95(Spec No 5):2002;31-39
70. Hood M.A., Smith W.M. Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial. Am. Heart J. 123:1992;1543-1549
71. Morrison L.J., Allan R., Vermeulen M., et al. Conversion rates for prehospital paroxysmal supraventricular tachycardia (PSVT) with the addition of adenosine: a before-and-after trial. Prehosp. Emerg. Care. 5:2001;353-359
72. Arnold R.W. The human heart rate response profiles to five vagal maneuvers. Yale J. Biol. Med. 72:1999;237-244
73. Wen Z.C., Chen S.A., Tai C.T., et al. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation. 98:1998;2716-2723
74. Mehta D., Wafa S., Ward D.E., et al. Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet. 1:1988;1181-1185
75. Domanovits H., Laske H., Stark G., et al. Adenosine for the management of patients with tachycardias - a new protocol. Eur. Heart J. 15:1994;589-593
76. Martynyuk A.E., Seubert C.N., Zima A., et al. Contribution of I(K, ADO) to the negative dromotropic effect of adenosine. Basic Res. Cardiol. 97:2002;286-294
77. Tai C.T., Chen S.A., Chiang C.E., et al. Influence of beta-adrenergic and vagal activity on the effect of exogenous adenosine on supraventricular tachycardia termination. Am. J. Cardiol. 79(15):1997;1628-1631
78. Chang K.C., Lin Y.C., Chen J.Y., et al. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine. Cardiology. 97:2002;138-146
79. Martynyuk A.E., Zima A., Seubert C.N., et al. Potentiation of the negative dromotropic effect of adenosine by rapid heart rates: possible ionic mechanism. Basic Res. Cardiol. 97:2002;295-304
80. Tonkin A.M., Aylward P.E., Joel S.E., et al. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia. J. Cardiovasc. Pharmacol. 2:1980;473-486
81. Prystowsky E.N. The effects of slow channel blockers and beta blockers on atrioventricular nodal conduction. J. Clin. Pharmacol. 28:1988;6-21
82. Tonkin A.M., Shorne L. The prophylaxis of AV nodal re-entry tachycardia. Clin. Exp. Pharmacol. Physiol. Suppl. 6:1982;135-143
83. Iinuma H., Dreifus L.S., Price R., et al. Influence of the site of stimulation on atrioventricular nodal refractory periods and the effect of verapamil. Am. J. Cardiol. 57:1986;1167-1174
84. Stark G., Kasper K., Schulze-Bauer C., et al. How to measure AV nodal refractoriness in the presence of verapamil, amiodarone, digoxin, and diltiazem. Pacing Clin. Electrophysiol. 19:1996;157-164
85. Segawa K. The relationship between refractory period and conduction time of the AV node under various cycle lengths in the canine heart. The significance of wavelength and excitable gap in reentrant tachycardia. Jpn. Heart J. 37:1996;373-382
86. Yue L., Feng J.L., Wang Z., et al. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes. Cardiovasc. Res. 46:2000;151-161
87. + channels IKr and IKs. Therapie. 55:2000;195-202
88. + channel block by verapamil and related compounds in rat alveolar epithelial cells. J. Gen. Physiol. 106:1995;745-779
89. Talajic M., Nattel S. Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: demonstration and characterization in anesthetized dogs. Circulation. 74:1986;1156-1167
90. Stark G., Schulze-Bauer C., Stark U., et al. Comparison of the frequency-dependent effects on the atrioventricular node of verapamil, amiodarone, digoxin, and diltiazem in isolated guinea pig hearts. J. Cardiovasc. Pharmacol. 25:1995;330-335
91. Lang J., Timour Chah Q., Charve P., et al. Role of calcium in the rate-dependent depression of atrioventricular nodal conduction in the dog heart under vagal influence. Int. J. Cardiol. 15:1987;65-76
92. Qi A.Z., Tuna I.C., Gornick C.C., et al. Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation. Circulation. 75:1987;888-893
93. Hassan S.A., Oral H., Scharf C., et al. Rate-dependent effect of verapamil on atrial refractoriness. J. Am. Coll. Cardiol. 41:2003;446-451
94. Sato N., Tanaka H., Habuchi Y., et al. Electrophysiological effects of ibutilide on the delayed rectifier K(+) current in rabbit sinoatrial and atrioventricular node cells. Eur. J. Pharmacol. 404:2000;281-288
95. Fujino H., Fujiseki Y., Shimada M. Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children. J. Cardiol. 19:1989;307-315
96. Bhandari A.K. Atrial Tachycardia. Curr. Treat Options Cardiovasc. Med. 1:1999;107-116
97. Steinbeck G, Hoffmann E. 'True' atrial tachycardia. Eur Heart J 1998;19(Suppl E):E10-2, E48-9
98. Simons G.R., Wharton J.M. Radiofrequency catheter ablation of atrial tachycardia and atrial flutter. Coron. Artery Dis. 7:1996;12-19
99. Dierkes S., Vester E.G., Dobran L.J., et al. Adenosine in the noninvasive diagnosis of dual AV nodal conduction: use as a follow-up parameter after slow pathway ablation in AVNRT. Acta Cardiol. 56:2001;103-108
100. Maglana M.P., Kam R.M., Teo W.S. The differential diagnosis of supraventricular tachycardia using clinical and electrocardiographic features. Ann. Acad. Med. Singapore. 29:2000;653-657
101. Maury P., Zimmermann M., Metzger J. Distinction between atrioventricular reciprocating tachycardia and atrioventricular node re-entrant tachycardia in the adult population based on P wave location. Should we reconsider the value of some ECG criteria according to gender and age? Europace. 5:2003;57-64
102. Ho Y.L., Lin L.Y., Lin J.L., et al. Usefulness of ST-segment elevation in lead aVR during tachycardia for determining the mechanism of narrow QRS complex tachycardia. Am. J. Cardiol. 92:2003;1424-1428
103. Page R.L., Wilkinson W.E., Clair W.K., et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 89:1994;224-227